tradit
epidemiolog
control
viral
infect
depend
isol
case
quarantin
contact
person
protect
infect
control
measur
mass
vaccin
specif
antivir
treatment
gener
avail
viral
infect
tabl
scenario
rapidli
chang
increas
avail
rapid
diagnost
test
use
nucleic
acid
amplif
develop
increas
number
effect
antivir
agent
common
acut
viral
diseas
respiratori
diarrheal
exanthemat
neurolog
infect
overlap
appear
season
epidem
peak
incid
everi
year
coincid
accumul
suffici
number
nonimmun
host
young
popul
arbovir
diseas
activ
often
coincid
arthropod
vector
activ
mosquito
breed
hot
raini
season
associ
increas
incid
hemorrhag
fever
neurolog
diseas
dengu
hemorrhag
fever
west
nile
viru
japanes
enceph
southeast
asia
mani
chronic
bloodborn
viral
ill
human
immunodefici
viru
hiv
hepat
b
viru
hbv
hepat
c
viru
hcv
still
take
major
toll
certain
geograph
region
due
specif
human
behavior
vertic
transmiss
chronic
viral
infect
hbv
hcv
hiv
polyomavirus
papillomavirus
also
link
genesi
cancer
emerg
viral
infect
ebola
viru
sever
acut
respiratori
syndrom
sar
coronaviru
middl
east
respiratori
syndrom
coronaviru
merscov
associ
acut
explos
outbreak
viru
jump
speci
barrier
bat
anim
human
tabl
articl
focu
prevent
control
viral
infect
articl
encyclopedia
cover
inform
specif
virus
unlik
bacteria
fungi
parasit
virus
small
visibl
light
microscopi
moreov
virus
oblig
intracellular
pathogen
grow
artifici
cultur
medium
collect
correct
clinic
specimen
peak
viral
shed
appropri
viral
transport
medium
crucial
accur
diagnosi
electron
microscopi
sensit
limit
role
examin
fece
viral
gastroenter
vesicular
fluid
skin
lesion
caus
herpesvirus
poxvirus
viru
isol
cell
line
chick
embryo
gold
standard
virolog
diagnosi
seldom
alter
clinic
manag
due
long
turnaround
time
viral
antigen
detect
immunofluoresc
enzym
immunoassay
pointofcar
rapid
later
flow
immunochromatograph
assay
signific
impact
therapeut
infect
control
strategi
import
rapid
virolog
test
nucleic
acid
amplif
test
realtim
multiplex
revers
transcriptionpolymeras
chain
reaction
rtpcr
assay
use
accur
diagnosi
subsequ
viral
load
monitor
antivir
treatment
genotyp
nucleic
acid
amplif
sequenc
detect
mutat
associ
antivir
resist
directli
clinic
specimen
avail
mani
antivir
agent
routin
antiretrovir
drug
use
treat
hiv
infect
though
nucleic
acid
amplif
test
still
practic
limit
field
set
develop
area
test
routin
hospit
develop
countri
antibodi
test
enzym
immunoassay
igm
acut
infect
igg
immun
statu
expos
individu
retrospect
diagnosi
presenc
rise
antibodi
titer
pair
acut
convalesc
sera
symptomat
patient
use
make
clinic
epidemiolog
decis
antibodi
screen
especi
import
antenat
visit
expect
mother
blood
donor
organ
donor
recipi
transplant
nextgener
sequenc
perform
directli
clinic
specimen
may
revolution
virolog
diagnosi
come
decad
time
accur
diagnosi
viral
infect
import
implic
effect
epidemiolog
control
commun
infect
control
hospit
outbreak
transmiss
bloodborn
virus
result
sexual
intercours
maternalfet
transmiss
commun
set
needl
stick
injuri
exposurepron
procedur
healthcar
set
studi
usa
annual
death
rate
healthcar
worker
occup
event
estim
per
million
worker
death
result
infectionrel
complic
bloodborn
virus
sepkowitz
eisenberg
overal
risk
transmiss
bloodborn
virus
hollow
needl
stick
injuri
sourc
hepat
carrier
posit
hbe
antigen
high
viral
load
hepat
c
carrier
viremia
hiv
respect
complianc
standard
precaut
includ
wear
glove
handl
blood
patient
care
practic
dispos
sharp
needl
punctureresist
box
avoid
recap
needl
remain
import
way
prevent
nosocomi
acquisit
bloodborn
virus
garner
activ
immun
hbv
protect
healthcar
worker
hbv
infect
efficaci
dienstag
et
al
sabido
et
al
shim
et
al
postimmun
antihb
antibodi
level
measur
week
complet
immun
regimen
given
baselin
month
month
good
respond
defin
person
whose
antihb
antibodi
level
greater
iul
hepat
b
antibodi
level
iul
booster
dose
vaccin
given
nonrespond
whose
antihb
antibodi
less
iul
anoth
cours
hbv
vaccin
given
respons
rate
repeat
hbv
vaccin
rout
initi
vaccin
struve
et
al
altern
immun
highdos
intraderm
recombin
hbv
vaccin
given
four
dose
achiev
immun
healthcar
worker
fail
respond
intramuscular
vaccin
booster
levitz
et
al
antihb
titer
persist
higher
protect
level
least
year
primari
hbv
vaccin
floreani
et
al
healthcar
worker
sustain
needl
stick
injuri
advis
rins
wound
tap
water
allow
natur
bleed
sourc
patient
blood
collect
check
presenc
hiv
hbv
hcv
statu
bloodborn
virus
sourc
patient
posit
unknown
postexposur
prophylaxi
pep
offer
accord
current
guidelin
kuhar
et
al
expos
healthcar
worker
close
follow
counsel
baselin
followup
hiv
test
monitor
drug
toxic
newer
fourthgener
combin
hiv
antigenhiv
antibodi
test
util
followup
hiv
test
may
conclud
month
exposur
otherwis
followup
hiv
test
perform
month
exposur
kuhar
et
al
hbv
pep
hepat
b
immun
globulin
hbig
andor
hbv
vaccin
consid
occup
exposur
evalu
hbsag
statu
sourc
vaccin
vaccinerespons
statu
expos
person
hcv
pep
current
recommend
howev
openlabel
pilot
trial
conduct
determin
safeti
toler
accept
peginterferon
pep
among
healthcar
worker
expos
hcv
antibodyposit
sourc
hcw
enrol
studi
elect
undergo
peginterferon
studi
group
seven
subject
elect
undergo
pep
treat
control
group
pilot
studi
peginterferon
proven
safe
without
seriou
advers
rural
resid
contact
bat
organ
transplant
dietzschold
koprowski
kusn
smilack
effect
howev
lack
hcv
transmiss
studi
control
group
support
routin
use
pep
healthcar
worker
hcv
exposur
corey
et
al
like
new
polymeras
proteas
inhibitor
use
treatment
hcv
infect
result
new
strategi
pep
hcv
exposur
bloodborn
virus
also
transmit
healthcar
worker
patient
especi
exposurepron
procedur
dental
cardiothorac
oper
wellknown
exampl
involv
hivposit
dentist
work
florida
usa
infect
five
patient
perform
invas
dental
procedur
sequenc
hiv
provir
envelop
gene
show
virus
infect
dentist
five
patient
close
relat
howev
overal
risk
transmiss
hiv
healthcar
worker
patient
small
studi
conduct
center
diseas
control
prevent
cdc
patient
care
hivposit
healthcar
worker
patient
becam
hiv
posit
epidemiolog
investig
implic
healthcar
worker
sourc
infect
patient
robert
et
al
contrast
transmiss
hbv
hcv
healthcar
worker
patient
frequent
document
august
juli
patient
oper
thorac
surgeon
acut
hbv
infect
becam
hbvinfect
sequenc
base
core
region
hbv
show
indistinguish
pattern
among
strain
surgeon
nine
infect
patient
harpaz
et
al
subsequ
numer
healthcar
workertopati
transmiss
hbv
hcv
report
among
report
case
viral
load
index
healthcar
worker
genom
copi
per
ml
buster
et
al
gunson
et
al
connect
societi
healthcar
epidemiolog
america
shea
issu
guidelin
manag
healthcar
worker
infect
hiv
hbv
hcv
impos
restrict
differ
categori
exposurepron
procedur
accord
viral
load
henderson
et
al
epidemiolog
import
respiratori
virus
influenza
viru
predominantli
transmit
droplet
rout
definit
viru
spread
within
index
case
howev
individu
infect
influenza
viru
may
produc
mani
droplet
mm
size
expel
veloc
upon
sneez
tang
et
al
droplet
nuclei
less
mm
may
suspend
air
settl
onto
ground
knight
therefor
explos
outbreak
high
clinic
attack
rate
result
aerosol
transmiss
may
occur
special
condit
jet
airlin
nonfunct
ventil
system
passeng
develop
influenzalik
ill
within
h
kept
ground
h
due
delay
flight
time
moser
et
al
viru
may
surviv
inanim
surfac
h
surfac
hand
min
kampf
kramer
kramer
et
al
influenza
viru
transmit
indirectli
contact
hand
contamin
environ
pharyng
mucosa
symptomat
influenza
may
develop
intranas
inocul
tcid
influenza
viru
tellier
hand
hygien
alway
core
compon
infect
control
measur
commun
hospit
prevent
transmiss
influenza
viru
wear
face
mask
either
index
case
sourc
control
healthcar
worker
contact
shown
equal
effect
control
nosocomi
transmiss
pandem
influenza
cheng
et
al
hand
hygien
face
mask
shown
prevent
household
transmiss
influenza
viru
implement
within
h
index
patient
symptom
onset
oseltamivir
pep
halt
outbreak
pandem
influenza
secondari
school
asiedubeko
et
al
nurs
home
van
der
sand
et
al
prevent
nosocomi
transmiss
influenza
viru
requir
multipl
action
earli
identif
symptomat
case
direct
antigen
detect
nasopharyng
specimen
initi
droplet
precaut
wear
surgic
mask
along
staff
educ
could
achiev
reduct
nosocomi
pandem
influenza
near
zero
cheng
et
al
similar
protocol
also
effect
minim
risk
nosocomi
transmiss
avian
influenza
viru
cheng
et
al
ensur
hand
hygien
complianc
directli
observ
hand
hygien
adopt
control
spread
respiratori
virus
hospit
cheng
et
al
cheng
et
al
alcoholbas
hand
rub
deliv
everi
healthcar
worker
consciou
patient
everi
h
clinic
area
may
reduc
spread
respiratori
virus
varicella
zoster
viru
vzv
measl
predominantli
transmit
aerosol
deposit
distal
airway
roy
milton
exact
mechan
airborn
transmiss
remain
elucid
howev
earli
studi
demonstr
nosocomi
outbreak
vzv
occur
even
index
case
strictli
isol
singl
room
gustafson
et
al
lack
nosocomi
spread
vzv
index
case
place
neg
pressur
airborn
infect
isol
room
anderson
et
al
measl
viru
surviv
air
least
h
shown
outbreak
three
suscept
children
contract
measl
never
room
sourc
patient
one
three
arriv
offic
h
sourc
patient
left
bloch
et
al
massiv
commun
outbreak
measl
occur
modern
suburban
elementari
school
new
york
spring
index
case
produc
secondari
case
differ
classroom
epidem
subsid
two
subsequ
gener
children
infect
estim
major
physic
biolog
factor
possibl
calcul
index
case
produc
approxim
unit
airborn
infect
quanta
per
minut
higher
patient
laryng
tuberculosi
riley
et
al
riley
et
al
earli
recognit
placement
airborn
infect
isol
room
index
case
vzv
measl
may
reduc
risk
nosocomi
outbreak
standard
transmissionbas
precaut
import
prevent
spread
respiratori
gastrointestin
viral
infect
tabl
respiratori
virus
respiratori
syncyti
viru
rsv
parainfluenza
viru
gastrointestin
virus
noroviru
rotaviru
predominantli
spread
direct
contact
illustr
exampl
rsv
frequent
caus
nosocomi
infect
pediatr
ward
caus
lower
respiratori
tract
diseas
young
children
prolong
shed
rsv
day
observ
immunocompet
children
hall
viru
surviv
inanim
surfac
h
kramer
et
al
factor
contribut
fomitemedi
transmiss
rsv
hospit
risk
nosocomi
rsv
transmiss
relat
age
underli
diseas
length
hospit
hall
et
al
contact
precaut
cohort
nurs
wear
glove
gown
patient
care
result
signific
reduct
nosocomi
transmiss
rsv
three
consecut
winter
madg
et
al
anoth
studi
incid
nosocomi
acquisit
rsv
significantli
decreas
implement
wear
glove
gown
isol
case
even
though
durat
rsv
shed
remain
unchang
intervent
leclair
et
al
gastrointestin
virus
noroviru
famou
agent
caus
outbreak
commun
hospit
transmiss
predominantli
fecalor
rout
numer
commun
outbreak
noroviru
report
restaur
resort
cruis
ship
school
nurs
home
arvelo
et
al
britton
et
al
kuo
et
al
lai
et
al
wikswo
et
al
emerg
new
variant
noroviru
genogroup
ii
type
australia
europ
north
america
associ
increas
acut
gastroenter
activ
report
sinc
bruggink
marshal
hase
et
al
kanerva
et
al
yen
et
al
noroviru
nonenvelop
rna
viru
relevantli
resist
common
disinfect
noroviru
uncultur
felin
caliciviru
use
surrog
vitro
vivo
test
differ
prepar
disinfect
gehrk
et
al
lage
et
al
formul
ahr
formula
prepar
contain
ethanol
vv
base
studi
may
possess
reason
virucid
activ
noroviru
contact
time
prolong
success
control
nosocomi
outbreak
noroviru
directli
observ
hand
hygien
report
especi
highrisk
nurs
care
practic
chang
napkin
feed
proactiv
infect
control
approach
provis
ad
test
implement
prevent
occurr
nosocomi
outbreak
new
variant
noroviru
tabl
infect
control
measur
transmissionbas
precaut
resourcepoor
area
cheng
et
al
rtpcr
noroviru
perform
ad
test
microbiolog
laboratori
fecal
specimen
request
bacteri
cultur
clostridium
difficil
cultur
cytotoxin
rotaviru
antigen
detect
without
request
noroviru
detect
studi
period
almost
newli
diagnos
noroviru
infect
detect
ad
test
time
implement
infect
control
measur
singl
room
isol
index
case
strict
contact
precaut
significantli
reduc
incid
hospitalacquir
noroviru
infect
baselin
case
per
potenti
infecti
patientday
p
cheng
et
al
diseas
outbreak
sar
pandem
influenza
ebola
outbreak
sar
first
emerg
import
human
pathogen
twentyfirst
centuri
sar
emerg
outbreak
atyp
acut
communityacquir
pneumonia
late
epidem
may
start
bat
sar
coronaviru
jump
cage
palm
civet
wildlif
market
becam
adapt
amplifi
jump
civet
human
infect
chef
anim
handler
transmit
adapt
viru
healthcar
worker
epidem
becam
amplifi
commun
epidem
rapidli
global
dissemin
superspread
sar
medic
professor
teach
hospit
guangzhou
went
hong
kong
februari
stay
hotel
transmit
sarscov
resid
secondari
case
spread
diseas
hospit
patient
hong
kong
countri
includ
vietnam
singapor
canada
eventu
total
patient
infect
countri
among
five
contin
die
cheng
et
al
nosocomi
outbreak
report
mani
part
world
includ
toronto
hong
kong
guangzhou
kaohsiung
singapor
vietnam
sar
epidem
total
secondari
tertiari
case
sar
result
admiss
infect
index
patient
healthcar
worker
constitut
secondari
tertiari
case
cheng
et
al
known
effect
antivir
agent
vaccin
treatment
prevent
sar
infect
control
measur
extens
trace
quarantin
contact
person
becam
import
intervent
sar
control
longitudin
followup
sar
patient
reveal
viral
load
gradual
increas
day
symptom
onset
peak
day
earli
isol
sourc
patient
prevent
ongo
transmiss
sar
commun
hospit
temporari
suspens
clinic
servic
inpati
outpati
set
adopt
gopalakrishna
et
al
liu
et
al
nishiura
et
al
reynold
et
al
home
quarantin
healthcar
worker
contact
sar
patient
also
mandat
center
dwosh
et
al
provis
person
protect
equip
ppe
respir
glove
gown
goggl
placement
suspect
confirm
case
sar
airborn
infect
isol
room
enforc
resourc
avail
appropri
use
ppe
also
import
staff
protect
mani
healthcar
worker
appar
lack
clear
understand
best
remov
ppe
without
contamin
littl
inform
appropri
sequenc
remov
ppe
avail
time
puro
nicastri
infect
control
measur
particularli
import
emerg
viral
infect
without
effect
antivir
therapi
vaccin
recent
largest
outbreak
ebola
viru
diseas
evd
west
africa
guinea
sierra
leon
liberia
nigeria
provinc
democrat
republ
congo
result
total
case
death
januari
ebola
viru
transmit
via
contact
contamin
bodi
fluid
contamin
environ
therefor
practic
contact
precaut
appropri
ppe
utmost
import
handl
suspect
confirm
evd
case
healthcar
worker
prefer
work
pair
mutual
observ
laps
infect
control
measur
requir
put
ppe
follow
sequenc
respir
waterrepel
cap
hood
fulllength
shoe
cover
boot
waterresist
gown
face
shield
final
long
nitril
glove
patient
hemorrhag
symptom
doubl
nitril
glove
worn
view
high
virul
mortal
patient
suspect
evd
isol
airborn
isol
room
although
allow
cohort
nurs
design
area
dedic
instrument
access
restrict
develop
countri
limit
isol
facil
degown
remain
critic
procedur
healthcar
worker
contamin
ppe
remov
first
start
long
nitrit
glove
waterresist
gown
fulllength
shoe
cover
boot
face
shield
waterrepel
cap
hood
final
respir
hand
hygien
alcoholbas
hand
rub
perform
step
degown
hand
visibl
soil
wash
soap
water
healthcar
worker
must
well
train
audit
proper
procedur
gown
degown
suspect
confirm
case
evd
die
healthcar
mortuari
worker
requir
wear
ppe
describ
dead
bodi
place
doubl
bag
leakproof
characterist
less
mm
thick
absorb
materi
put
bodi
place
first
bag
surfac
bodi
bag
wipe
ppm
sodium
hypochlorit
solut
bag
seal
label
indic
highli
infecti
materi
categori
move
mortuari
immedi
view
funer
parlor
embalm
hygien
prepar
allow
dead
bodi
remov
bodi
bag
sent
cremat
soon
possibl
august
declar
evd
outbreak
west
africa
public
health
emerg
intern
concern
prepared
respons
plan
made
avail
health
author
nearli
countri
worldwid
aim
detect
first
import
case
earli
isol
order
prevent
local
transmiss
commun
healthcar
set
therefor
risk
assess
port
emerg
room
outpati
clinic
patient
fulfil
clinic
epidemiolog
criteria
evd
import
clinic
definit
patient
suffer
elev
bodi
temperatur
subject
fever
symptom
includ
sever
headach
fatigu
muscl
pain
vomit
diarrhea
abdomin
pain
unexplain
hemorrhag
alert
epidemiolog
definit
includ
close
contact
confirm
probabl
case
evd
resid
histori
travel
affect
area
countri
guinea
liberia
sierra
leon
within
day
symptom
onset
healthcar
worker
work
volunt
medic
servic
nongovern
organ
direct
contact
patient
affect
area
countri
also
perform
medic
surveil
place
quarantin
least
day
leav
affect
area
countri
medic
evalu
sought
promptli
symptom
fever
diarrhea
vomit
bleed
quarantin
medic
surveil
refer
experi
commun
spread
pandem
influenza
viru
infect
nonpharmacolog
intervent
social
distanc
school
closur
evalu
previou
model
epidemiolog
studi
bell
et
al
bootsma
ferguson
ferguson
et
al
markel
et
al
influenza
pandem
school
closur
practic
usa
australia
bors
et
al
effler
et
al
school
closur
associ
reduct
mean
total
number
contact
student
report
retrospect
questionnair
survey
unit
kingdom
jackson
et
al
hong
kong
kindergarten
primari
school
close
local
transmiss
influenza
viru
identifi
follow
shortli
afterward
secondari
school
closur
summer
vacat
influenza
viru
transmiss
estim
reduc
wu
et
al
home
quarantin
also
shown
reduc
incid
pandem
influenza
workplac
miyaki
et
al
fact
home
quarantin
use
control
commun
spread
sar
beij
taiwan
singapor
toronto
center
diseas
control
prevent
cdc
cava
et
al
hsu
et
al
home
quarantin
consid
control
spread
ebola
viru
affect
countri
although
resourcelimit
set
effect
implement
strategi
challeng
local
govern
health
author
alreadi
implement
home
quarantin
day
urgent
infect
control
measur
howev
technic
polit
feasibl
home
quarantin
may
extend
day
one
incub
period
ebola
viru
diseas
howev
public
health
staff
expect
face
unpreced
challeng
implement
extens
quarantin
polici
dual
role
monitor
complianc
provid
support
peopl
quarantin
countri
close
proxim
affect
area
requir
implement
border
control
measur
screen
suspect
case
ebola
viru
even
consid
close
border
day
although
measur
may
advers
affect
intern
travel
local
economi
may
worthwhil
implement
strict
measur
control
reemerg
infecti
diseas
high
mortal
psycholog
fear
time
manner
current
avail
antivir
influenza
includ
adamantan
amantadin
rimantadin
neuraminidas
inhibitor
oseltamivir
zanamivir
peramivir
pyrazinecarboxamid
deriv
favipiravir
neuraminidas
inhibitor
pyrazinecarboxamid
deriv
activ
current
circul
influenza
virus
oseltamivir
favipiravir
avail
oral
zanamivir
avail
either
dri
powder
deliv
oral
inhal
recent
intraven
formul
avail
peramivir
avail
intraven
formul
random
control
trial
patient
season
influenza
suggest
use
neuraminidas
inhibitor
shorten
durat
ill
approxim
day
recent
metaanalysi
demonstr
earli
neuraminidas
inhibitor
treatment
within
day
symptom
onset
associ
reduct
mortal
muthuri
et
al
two
prospect
clinic
trial
demonstr
treatment
convalesc
plasma
hyperimmun
intraven
immunoglobulin
patient
sever
influenza
infect
associ
lower
viral
load
cytokin
level
reduc
mortal
clinic
trial
variou
antivir
treatment
evd
underway
agent
includ
novel
nucleosid
analog
juland
et
al
brincidofovir
favipiravir
tkmebola
zmapp
chimer
monoclon
antibodi
guinea
sierra
leon
liberia
bishop
highli
effect
antivir
treatment
sever
viral
ill
especi
patient
extrem
age
medic
comorbid
infect
control
measur
difficult
implement
compli
vaccin
final
option
prevent
massiv
outbreak
influenza
vaccin
wide
use
annual
vaccin
commun
healthcar
set
protect
risk
person
develop
influenzarel
complic
prevent
institut
outbreak
season
influenzarel
excess
hospit
death
estim
per
year
respect
hong
kong
subtrop
citi
chiu
et
al
wong
et
al
wong
et
al
metaanalysi
assess
influenza
vaccin
efficaci
effect
elderli
patient
inactiv
influenza
vaccin
could
reduc
risk
hospit
result
pneumonia
cardiovascular
diseas
caus
mortal
nichol
control
viru
diseas
outbreak
vaccin
particularli
valuabl
expos
individu
viral
diseas
long
enough
incub
period
expos
individu
suffici
time
develop
protect
immun
respons
symptomat
diseas
set
measl
incub
period
day
mump
incub
period
day
rubella
incub
period
day
varicella
incub
period
day
relev
exampl
reactiv
vaccin
measl
outbreak
shown
effect
measur
reduc
scale
outbreak
democrat
republ
congo
weekli
report
case
reduc
respect
week
follow
mass
vaccin
campaign
alberti
et
al
similarli
nationwid
mass
vaccin
interrupt
transmiss
paralyt
poliomyel
albania
total
paralyt
case
occur
attack
rate
per
popul
among
adult
age
year
epidem
control
two
round
mass
vaccin
trival
oral
polioviru
vaccin
target
person
age
year
prevot
et
al
routin
laboratori
diagnost
test
specif
antimicrobi
agent
gener
avail
treatment
bacteri
fungal
parasit
infect
enter
stage
rapid
nucleic
acid
test
greater
array
antivir
agent
avail
tackl
viral
infect
broad
array
virus
worldwid
caus
substanti
morbid
mortal
rang
respiratori
virus
arthropodrel
virus
deadli
bloodborn
virus
novel
emerg
reemerg
virus
caus
major
epidem
time
time
especi
dens
popul
area
human
popul
close
contact
wild
anim
wildlif
market
food
anim
wet
market
abattoir
epidem
ebola
viru
diseas
explos
countri
fail
govern
poor
health
infrastructur
current
lack
antivir
treatment
infect
therefor
prevent
implement
effect
infect
control
vaccin
utmost
import
contain
virus
see
also
arbovirus
hiv
safeti
guidelin
hepat
viral
influenza
measl
mump
rabi
respiratori
syncyti
viru
rubella
